|
시장보고서
상품코드
2039019
트라조돈(Trazodone) 시장 : 제품 유형별, 제형별, 유효 성분 함유량별, 적응증별, 유통 채널별, 지역별Trazodone Market, By Product Type, By Form, By Strength, By Indication, By Distribution Channel, By Geography |
||||||
트라조돈 시장은 2026년에 6억 8,720만 달러로 추정되며, 2033년까지 9억 740만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 4.1%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 6억 8,720만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 4.10% | 2033년 시장 규모 예측: | 9억 740만 달러 |
세계 트라조돈 시장은 현대 임상에서 널리 사용되는 비정형 항우울제를 기반으로 제약 산업에서 중요한 부문을 구성하고 있습니다. 트라조돈은 항우울제와 최면제로서의 이중 효과로 인해 높은 평가를 받고 있습니다. 1980년대 도입된 이래로 주요우울장애, 불면증, 불안장애, 만성 통증관리 등 다양한 적응증에서 가장 많이 처방되는 약제 중 하나입니다. 이 약은 50mg, 100mg, 150mg, 300mg의 다양한 용량으로 제공되는 속방정 및 서방정 등 다양한 제형이 있습니다.
전 세계적으로 정신질환 및 수면장애 사례가 증가하고, 정신보건에 대한 편견이 해소되면서 이 산업이 발전하는 데 중요한 역할을 했습니다. 따라서 트라조돈은 항우울제 분야의 주요 약물이 되어 제약회사에 안정적인 수익원을 제공하고 있습니다. 따라서 대형 제약사와 제네릭 제약사 모두 주목해야 할 타겟이 되고 있습니다.
시장 역학
세계보건기구(WHO)에 따르면, 우울증은 전 세계적으로 가장 흔한 장애의 원인으로 꼽히고 있으며, 이에 따라 효과적인 항우울제에 대한 수요가 증가하고 있습니다. 따라서 우울증과 불면증 치료에 효과가 있는 트라조돈의 이중적 특성은 두 가지 증상 모두에 시달리는 사람들에게 매우 유용합니다. 또한, 트라조돈은 항콜린 작용이 적어 다른 항우울제에 비해 선호도가 높기 때문에 고령화도 시장 성장을 견인할 것으로 예상됩니다.
그러나 시장 성장을 저해하는 요인으로는 제네릭 의약품과의 치열한 경쟁을 꼽을 수 있습니다. 이로 인해 약값에 대한 압박이 발생하여 수익에 악영향을 미칠 수 있습니다. 심장 부정맥, 지속성 발기부전 등 안전성에 대한 우려도 시장에 영향을 미칠 수 있는 요인으로 꼽힙니다. 특허 만료와 높은 승인 비용으로 인해 경쟁이 심화되는 한편, 신규 제제 개발이 어려워지고 있습니다. 그러나 섬유근육통, 외상 후 스트레스 장애(PTSD), 물질사용장애 등 적응증 외의 질환에서 이 약의 사용을 모색할 수 있는 기회는 많이 있습니다.
본 조사의 주요 특징
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 시장 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택한 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 다음과 같은 매개 변수(회사 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과, 전략)를 기반으로 세계 트라조돈 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것으로 기대됩니다.
- 이 트라조돈 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 금융 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 트라조돈 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 트라조돈 시장 : 제품 유형별, 2021-2033년
제5장 세계의 트라조돈 시장 : 제형별, 2021-2033년
제6장 세계의 트라조돈 시장 : 유효 성분 함유량별, 2021-2033년
제7장 세계의 트라조돈 시장 : 적응증별, 2021-2033년
제8장 세계의 트라조돈 시장 : 유통 채널별, 2021-2033년
제9장 세계의 트라조돈 시장 : 지역별, 2021-2033년
제10장 경쟁 구도
제11장 애널리스트의 추천
제12장 참고문헌 및 조사 방법
KSM 26.06.04Trazodone Market is estimated to be valued at USD 687.2 Mn in 2026 and is expected to reach USD 907.4 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 687.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.10% | 2033 Value Projection: | USD 907.4 Mn |
The global trazodone market constitutes a significant segment in the pharmaceutical industry based on an atypical antidepressant medication that enjoys wide acceptance in contemporary clinical practice. Trazodone is highly regarded for its two-way effect as an antidepressant and hypnotic agent. Since its introduction into the market in the 1980s, it has become one of the most frequently prescribed drugs for major depressive disorder, insomnia, anxiety disorders, and chronic pain management, among other applications. Different forms of the drug include immediate-release and extended-release tablets available in different dosages of 50 mg, 100 mg, 150 mg, and 300 mg.
The rise in cases of mental disorders and sleep disorders around the globe, combined with the process of de-stigmatization of mental health care, has played an important role in the development of the industry. As such, trazodone has become a key drug within the antidepressant segment, providing manufacturers with a reliable revenue stream. Hence, it is a target of interest for both major pharmaceutical companies and generics makers.
Market Dynamics
The global trazodone market has been fueled by the high incidence rates of depression and anxiety, since according to the World Health Organization, depression is considered the most common source of disability across the globe, thus resulting in an increased demand for effective antidepressants. The dual nature of trazodone, which provides benefits for the treatment of both depression and insomnia, makes it highly useful for individuals suffering from both conditions. The aging population is also expected to fuel growth in the market because trazodone is more favorable when compared with other antidepressants on account of its low anticholinergic burden.
However, some obstacles to growth in the market include heavy competition from generics that can put price pressures on the drugs and negatively impact their revenues. Concerns regarding safety such as heart arrhythmias and priapism could be other considerations that may affect the market. Expired patents and high approval costs have only served to heighten the level of competition while making it difficult to develop a novel formulation. There are, however, plenty of chances to pursue the use of the drug in treating off-label conditions such as fibromyalgia, post-traumatic stress disorder (PTSD), and substance addiction disorders.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global trazodone market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Teva Pharmaceutical Industries Ltd., Viatris Inc., Sandoz, Pfizer Inc., Sun Pharmaceutical Industries Ltd., Angelini Pharma S.p.A., The Piramal Group, Fermion Oy, Apotex Inc., and Zydus Lifesciences Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global trazodone market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global trazodone market
Market Segmentation
- Product Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generics
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Immediate Release Tablets
- Extended-Release Oral Tablets
- Strength Insights (Revenue, USD Mn, 2021 - 2033)
- 50 mg
- 100 mg
- 150 mg
- 300 mg
- Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Depression
- Anxiety
- Insomnia
- Others
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
- Sandoz
- Pfizer Inc.
- Sun Pharmaceutical Industries Ltd.
- Angelini Pharma S.p.A.
- The Piramal Group
- Fermion Oy
- Apotex Inc.
- Zydus Lifesciences Ltd.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Trazodone Market, By Product Type
- Global Trazodone Market, By Form
- Global Trazodone Market, By Strength
- Global Trazodone Market, By Indication
- Global Trazodone Market, By Distribution Channel
- Global Trazodone Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
4. Global Trazodone Market, By Product Type, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Branded
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Trazodone Market, By Form, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Immediate Release Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Extended-Release Oral Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Trazodone Market, By Strength, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- 50 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 100 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 150 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- 300 mg
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Trazodone Market, By Indication, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Anxiety
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Insomnia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
8. Global Trazodone Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
9. Global Trazodone Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Strength, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Angelini Pharma S.p.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- The Piramal Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Fermion Oy
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Apotex Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Lifesciences Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
